Utah Medical Products | UTMD - Equity Capital And Reserves


Utah Medical Products reported $120.37M in Equity Capital and Reserves for its fiscal quarter ending in March of 2026.





Equity Capital And Reserves Change Date
AngioDynamics USD 176.33M 2.52M Sep/2025
Baxter International USD 6.21B 163M Jun/2026
Cerus USD 64.22M 2.76M Dec/2025
CONMED USD 1.04B 23.72M Jun/2026
Cooper Companies USD 8.36B 124.7M Dec/2025
General Electric Aerospace USD 17.64B 417M Jun/2026
Integra LifeSciences USD 1.04B 971K Jun/2026
J&J USD 84.97B 3.78B Jun/2026
Medtronic USD 48.99B 128M Dec/2025
Merit Medical Systems USD 1.68B 53.08M Jun/2026
OraSure Technologies USD 317.78M 4.45M Jun/2026
Rockwell Medical USD 30.41M 1.11M Jun/2025
STAAR Surgical USD 365.4M 13.03M Jun/2026
Stryker USD 22.98B 559M Mar/2026
Teleflex USD 2.9B 179.9M Jun/2026
Utah Medical Products USD 120.37M 1.1M Mar/2026
West Pharmaceutical Services USD 2.99B 200K Jun/2026